| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |